Portfolio (Quarterly)
Guide ↗
SILVERARC CAPITAL MANAGEMENT, LLC
· CIK 0001816307| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 348,569.0 | $10.8M | 1.51% | +89K | +34.3% | $31.12 | -45.2% |
| 22 | — | ASCENDIS PHARMA A/S | — | 49,228.0 | $10.5M | 1.46% | -4K | -8.1% | $213.24 | — |
| 23 | PFE | PFIZER INC | Healthcare | 419,134.0 | $10.4M | 1.45% | NEW | — | $24.90 | +3.4% |
| 24 | — | BENITEC BIOPHARMA INC | — | 731,717.0 | $9.9M | 1.37% | +455K | +164.9% | $13.47 | — |
| 25 | — | AVALO THERAPEUTICS INC | — | 524,436.0 | $9.5M | 1.32% | -196K | -27.2% | $18.16 | — |
| 26 | GH | GUARDANT HEALTH INC | Healthcare | 91,914.0 | $9.4M | 1.30% | NEW | — | $102.14 | -3.4% |
| 27 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 1,116,604.0 | $9.1M | 1.27% | -832K | -42.7% | $8.18 | +2.0% |
| 28 | PCVX | VAXCYTE INC | Healthcare | 148,787.0 | $6.9M | 0.95% | -166K | -52.7% | $46.14 | +16.0% |
| 29 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 541,240.0 | $6.8M | 0.94% | -48K | -8.1% | $12.52 | +20.4% |
| 30 | GOSS | GOSSAMER BIO INC | Healthcare | 2,135,722.0 | $6.6M | 0.92% | -2.6M | -55.3% | $3.10 | -89.0% |
| 31 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 187,737.0 | $6.2M | 0.85% | NEW | — | $32.76 | +130.9% |
| 32 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 617,608.0 | $6.1M | 0.85% | -161K | -20.7% | $9.93 | -44.6% |
| 33 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 506,242.0 | $6.1M | 0.85% | -194K | -27.7% | $12.08 | +10.0% |
| 34 | CERS | CERUS CORP | Healthcare | 2,814,383.0 | $5.8M | 0.81% | +99K | +3.6% | $2.06 | +13.6% |
| 35 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 1,051,343.0 | $5.6M | 0.78% | -1.8M | -62.9% | $5.37 | -65.4% |
| 36 | — | SOLENO THERAPEUTICS INC | — | 117,485.0 | $5.4M | 0.76% | NEW | — | $46.30 | — |
| 37 | CGEN | COMPUGEN LTD | Healthcare | 3,479,805.0 | $5.3M | 0.74% | +169K | +5.1% | $1.53 | +79.7% |
| 38 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 191,074.0 | $5.2M | 0.72% | -158K | -45.2% | $27.16 | +15.4% |
| 39 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 206,280.0 | $5.2M | 0.72% | -727K | -77.9% | $25.00 | -44.7% |
| 40 | ERAS | ERASCA INC | Healthcare | 1,317,584.0 | $4.9M | 0.68% | -50K | -3.7% | $3.72 | +178.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%